1. Home
  2. ITOS vs IBEX Comparison

ITOS vs IBEX Comparison

Compare ITOS & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • IBEX
  • Stock Information
  • Founded
  • ITOS 2011
  • IBEX 2017
  • Country
  • ITOS United States
  • IBEX United States
  • Employees
  • ITOS N/A
  • IBEX N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • IBEX EDP Services
  • Sector
  • ITOS Health Care
  • IBEX Technology
  • Exchange
  • ITOS Nasdaq
  • IBEX Nasdaq
  • Market Cap
  • ITOS 446.6M
  • IBEX 385.9M
  • IPO Year
  • ITOS 2020
  • IBEX 2020
  • Fundamental
  • Price
  • ITOS $10.11
  • IBEX $28.76
  • Analyst Decision
  • ITOS Hold
  • IBEX Hold
  • Analyst Count
  • ITOS 6
  • IBEX 2
  • Target Price
  • ITOS $10.40
  • IBEX $27.00
  • AVG Volume (30 Days)
  • ITOS 1.6M
  • IBEX 87.0K
  • Earning Date
  • ITOS 08-06-2025
  • IBEX 09-11-2025
  • Dividend Yield
  • ITOS N/A
  • IBEX N/A
  • EPS Growth
  • ITOS N/A
  • IBEX 48.53
  • EPS
  • ITOS N/A
  • IBEX 2.25
  • Revenue
  • ITOS N/A
  • IBEX $535,666,000.00
  • Revenue This Year
  • ITOS N/A
  • IBEX $9.12
  • Revenue Next Year
  • ITOS N/A
  • IBEX $5.80
  • P/E Ratio
  • ITOS N/A
  • IBEX $12.76
  • Revenue Growth
  • ITOS 177.89
  • IBEX 5.35
  • 52 Week Low
  • ITOS $4.80
  • IBEX $15.95
  • 52 Week High
  • ITOS $18.13
  • IBEX $32.08
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 53.14
  • IBEX 47.11
  • Support Level
  • ITOS $10.08
  • IBEX $28.54
  • Resistance Level
  • ITOS $10.17
  • IBEX $29.61
  • Average True Range (ATR)
  • ITOS 0.04
  • IBEX 0.79
  • MACD
  • ITOS -0.02
  • IBEX -0.00
  • Stochastic Oscillator
  • ITOS 35.29
  • IBEX 43.39

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Share on Social Networks: